What Flowserve (FLS) Said on Its Q3 Earnings Call

Flowserve (FLS) reported Q3 earnings, noting an 8% decline in General Industries bookings due to prior-year comparisons, but growth in pharmaceutical, water, and mining sectors. Middle East disruptions led to a reduced sales outlook, with full-year organic sales expected to decline 1.5% to 2.5%. Despite this, adjusted EPS forecast was raised to $4.10-$4.20. Adjusted gross margin expanded to 36.7%, and the company generated $144M in operating cash flow.

Original reporting
Published Oct 30, 2026, 1:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Flowserve (FLS) Said on Its Q3 Earnings Call — source image
Decision brief

The 30-second read

$FLSNeutralMed
01

Why it matters

Guidance cut on sales suggests near‑term revenue pressure, but higher EPS guidance and margin improvements may cushion the stock.

02

Market read

Investors will reassess Flowserve's valuation based on the mixed guidance update and regional risk exposure.

03

What to watch

Potential upside from emerging data‑center cooling market and upcoming Trillium integration benefits.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

Flowserve reported Q3 results, highlighted Middle‑East operational challenges, and updated its full‑year guidance.

Company-level read

Ticker impact

$FLSNeutralHigh confidence
Context

Flowserve disclosed Q3 results, lowered full-year sales outlook to -1.5% to -2.5% and raised the low end of its FY adjusted EPS forecast to $4.10.

Expected impact

likely modest pressure as investors weigh lower sales against higher EPS guidance

Evidence & confidence

Sales decline signals near‑term revenue headwinds, while the EPS raise and margin expansion provide some upside support.

Market effects

Industrial equipment sector may see broader scrutiny of Middle‑East exposure.

Middle‑East disruption could affect other exporters with similar exposure.

Limited to investors in flow‑control and industrial machinery stocks.

Counterpoint

The EPS raise and margin expansion could outweigh the sales decline, offering a buying opportunity.

Key entities

  • Flowserve Corporation

    Global manufacturer of flow‑control equipment.

  • Brian Ezzell

    Chief Financial Officer who presented the guidance.

Related articles

$FLSMedAI 8/10

Flowserve Corp (FLS) (Q3 2026) Earnings Call Highlights: Record

Flowserve Corp (FLS) reported Q3 2026 earnings with bookings up 14% YoY to $1.4B, adjusted EPS up 19% to $1.07, and backlog at a record $3.5B. Organic sales declined 1% due to Middle East conflicts and portfolio actions. Free cash flow conversion guidance lowered to ~80%. Management expects future growth driven by aftermarket demand and backlog.

$FLSMed

Flowserve (FLS) Q3 2026 Earnings Call Transcript

Flowserve (FLS) updated its full-year guidance, revising sales outlook due to Middle East challenges and raising adjusted EPS guidance. Q3 bookings rose 14% with aftermarket and original equipment bookings increasing. Backlog reached a record $3.5B. Energy and power sectors showed growth, while general industries declined. Middle East conflicts impacted sales but long-term opportunities remain.

$FLSMedAI 8/10

Flowserve Q3 2026 slides: record backlog offsets Middle East headwinds

Flowserve (FLS) reported Q3 2026 earnings with adjusted EPS of $1.07, beating estimates, but revenue of $1.23B missed expectations. Bookings grew 14%, driving a record backlog of $3.5B. Adjusted operating margin expanded to 16.5%. The company lowered its sales outlook due to Middle East disruptions but maintained confidence in full-year organic bookings growth. Shares rose 8.12% post-earnings.

$FLSMedAI 8/10

Flowserve (NYSE:FLS) posts Q3 2026 sales in line with estimates

Flowserve reported Q3 2026 revenue of $1.24 billion, matching estimates, and adjusted EPS of $1.07, beating estimates by 9%. The company raised its full-year adjusted EPS guidance to $4.15 at the midpoint. Operating margin increased to 12.5%, while free cash flow margin dropped to 0%. Backlog grew 19.9% year on year to $3.47 billion.